Carlene Laverne Ohara, LPN | |
23814 State Highway T, Excello, MO 65247-2002 | |
(573) 489-0732 | |
Not Available |
Full Name | Carlene Laverne Ohara |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 23814 State Highway T, Excello, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154507135 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 043529 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Carlene Laverne Ohara, LPN 23814 State Highway T, Excello, MO 65247-2002 Ph: (573) 489-0732 | Carlene Laverne Ohara, LPN 23814 State Highway T, Excello, MO 65247-2002 Ph: (573) 489-0732 |
News Archive
Not enough American women understand that consuming the B vitamin folic acid every day can help prevent serious birth defects, and only 40 percent are taking daily multivitamin supplements containing this essential nutrient beginning before pregnancy, two recent surveys show.
Wearing face masks is widely recommended as the coronavirus disease (COVID-19) continues to ravage across the globe. The pandemic has now topped more than 16.66 million cases, with a staggering death toll of at least 659,000.
QIAGEN N.V. today announced that the Japanese Pharmaceuticals and Medical Device Agency has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer's VIZIMPRO (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent non-small cell lung cancer.
Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.
› Verified 9 days ago